- Pain Summit 2018
|New Frontiers in Inflammation Control | Pain Management Conference|
New Frontiers in Inflammation Control
Uncontrolled inflammation is now recognized to be a component of aging as well as many widely occurring chronic diseases. Learn about the latest advances in the biosynthesis and functions of specialized pro-resolving mediators (SPM) in inflammation and pain.
Professor Charles N. Serhan, PhD, D.Sc., is the Simon Gelman Professor of Anaesthesia (Biochemistry and Molecular Pharmacology) at Harvard Medical School and Professor of Oral Medicine, Infection and Immunity at Harvard School of Dental Medicine. He is Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital. Charles received a BS in biochemistry from Stony Brook University followed by a Doctorate in experimental pathology and medical sciences from New York University School of Medicine. He was a visiting scientist and post-doctoral fellow at the Karolinska Institutet, Stockholm with Professor Bengt Samuelsson ( Nobel Laureate Medicine -Physiology 82). In 1987, he joined the faculty at Harvard Medical School and received an honorary degree from Harvard University (1996). He has received several awards including an NIH MERIT award (2000) and has delivered > 50 keynote and plenary lectures. Among these, 2008 William Harvey Outstanding Scientist Medal and AAAS Fellow in 2011. In 2010, he received the Society for Leukocyte Biology Bonazinga Award for outstanding research on leukocytes, The American College of Rheumatology Hench (Nobel Laureate) Award Lecture in 2011, and Mérieux 2013 Laureate. In 2016, he received the IUBMB Lecture Metal and the Ross Prize in Molecular Medicine. This year he received the International Eicosanoid Research Foundation’s 2017 Lifetime Achievement Award and the American Society of Investigative Pathology (ASIP) 2018 Rous Whipple Award.
Dr. Serhan reports that he receives research support from Corbus and Solutex; scientific advisory board for Corbus and Inflammation Res Foundation; and is the associate editor of FASEB Journal.